CB-103
N/A
Report date: 2023/07/18 20:00:33
NME
Base Information
Drug NameCB-103
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[7]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesCellestia Biotech Ag
China Registration ClassN/A
Develop Information
Active CompaniesCellestia Biotech Ag
Inactive CompaniesDmed Biopharmaceutical Co LtdThe University Of Texas MD Anderson Cancer CenterGlatt Pharmaceutical Services Gmbh & Co Kg
Active Indications
Inactive Indications +[10]
Other Information
ATC CodeN/A
Related LinksN/A